NASDAQ · Medical - Devices

AXGN (AXGN) Stock

$40.48 +2.51% NASDAQ: AXGN Healthcare

Valuation

MetricValue
Price$40.48
Market Cap$2.15B
P/E Ratio60.40
P/B Ratio9.55
P/S Ratio9.82
EPS (TTM)$0.00
52-Week High$46.57
52-Week Low$9.22
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-17.96%
ROA-2.32%
ROCE-6.20%
Gross Margin75.01%
Operating Margin-3.79%
Net Margin-13.21%
Debt/Equity0.08
Current Ratio5.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$127.0M$139.0M$159.0M$187.0M$225.0M
Operating Profit$-25.0M$-30.0M$-21.0M$-3.0M$-8.0M
Net Profit$-27.0M$-29.0M$-22.0M$-10.0M$-16.0M
EPS$-0.65$-0.69$-0.51$-0.23$-0.34
Op Margin-20.0%-21.4%-13.5%-1.8%-3.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$208.0M$195.0M$197.0M$204.0M$222.0M
Total Liabilities$95.0M$94.0M$101.0M$100.0M$93.0M
Cash$33.0M$15.0M$31.0M$28.0M$36.0M
Borrowings$67.0M$67.0M$69.0M$69.0M$68.0M

Latest News

Axogen, Inc. to Report Second Quarter 2026 Financial Results on July 29, 2026 GlobeNewswire · Jul 15, 2026 Dow Jones AI Giant Nvidia Stock Tumbles To Key Support Level Amid Market Sell-Off Investor's Business Daily · Jun 9, 2026 Eli Lilly Leads Medical Stocks To Watch, While Google Finds Support Investor's Business Daily · Jun 6, 2026 AxoGen, Stock Of The Day, Offers Entry After Bullish Rebound Investor's Business Daily · Jun 5, 2026 AxoGen Says Nerve Repair Strategy Intact as Reimbursement Wins Gather Steam MarketBeat · May 14, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-13.0M$-16.0M$-6.0M$5.0M$1.0M
Investing Cash Flow$-52.0M$-24.0M$4.0M$-15.0M$-9.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$-17.0M$-17.0M$15.0M$-3.0M$6.0M
Free Cash Flow$-42.0M$-37.0M$-21.0M$0$-3.0M

Valuation & Return Ratios

MetricValue
PEG Ratio99.04
EV / EBITDA-1033.11
FCF Yield0.38%
Quick Ratio5.33
Interest Coverage-1.00
Return 1Y213.96%
Return 3Y349.43%
Return 5Y98.34%

Ownership

Insiders Held2.19%
Institutions Held93.86%
Institutions Float Held95.96%
Institutional HolderSharesReport Date
First Light Asset Management, LLC4,002,7682026-03-31
Blackrock Inc.3,870,8512026-03-31
Morgan Stanley3,122,9822026-03-31
Vanguard Capital Management LLC2,291,5632026-03-31
ArrowMark Colorado Holdings LLC1,915,4392026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AHCO $11.17 -0.45% 8.52 $1.52B 0.00%
CTEVClaritev Corporation $21.73 +0.56% -1.25 $370.45M 0.00%
IART $19.76 +1.15% 5.27 $1.54B 0.00%
INMD $15.38 +1.38% 9.72 $884.05M 0.00%
IRMD $95.08 +0.62% 46.31 $1.22B 1.43%

About AXGN

AXGN stock trades at $40.48 with a market capitalization of $2.15B. The stock is valued at a price-to-earnings (P/E) ratio of 60.40, price-to-book of 9.55, price-to-sales of 9.82. Over the past 52 weeks the stock has ranged between $9.22 and $46.57, and currently trades 13.1% below its 52-week high.

On profitability, AXGN generates a return on equity (ROE) of -17.96%, return on capital employed of -6.20%, an operating margin of -3.79%, a net profit margin of -13.21%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides